Scientists test new eczema drug pen vs. traditional shot
NCT ID NCT06438263
Summary
This study aimed to see if a new auto-injector pen delivers a drug for atopic dermatitis (eczema) as effectively as the standard vial and syringe method. It involved 231 healthy adults who received a single dose. Researchers measured the drug levels in the blood and monitored for side effects to compare the two delivery methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit - Dallas
Dallas, Texas, 75247-4968, United States
-
Fortrea Clinical Research Unit - Daytona Beach
Daytona Beach, Florida, 32117-5116, United States
-
Fortrea Clinical Research Unit Inc. - Madison
Madison, Wisconsin, 53704-2526, United States
Conditions
Explore the condition pages connected to this study.